Abstract
Purpose
The purpose of this study is to evaluate the pharmacokinetics and histopathological findings of transarterial chemoembolization (TACE) using cisplatin powder mixed with degradable starch microspheres (DSM) (Cis/DSM-TACE) compared with cisplatin arterial infusion (Cis-AI).
Materials and Methods
Eighteen rabbits with VX2 liver tumors were divided into two groups: Cis/DSM-TACE (n = 9) and Cis-AI (n = 9) groups. In the Cis/DSM-TACE group, a mixture of cisplatin powder and DSM was injected until stasis of hepatic arterial flow was achieved. In the Cis-AI group, cisplatin solution was infused.
Results
The platinum concentrations in VX2 tumors in the Cis/DSM-TACE group at 24 and 72 h were significantly elevated compared with those in the Cis-AI group (P = .016 and .019, respectively). There were no significant differences in the platinum concentrations in plasma. Histopathological examination revealed the presence of several microspheres inside the tumors at 1 h, which completely disappeared at 24 h. Tumor cell apoptosis at 1 h in the Cis/DSM-TACE group was more frequently observed compared with that in the Cis-AI group (P = .006).
Conclusions
TACE using cisplatin powder mixed with DSM provides a higher drug concentration in tumors, thereby achieving stronger antitumor effects compared with arterial infusion of cisplatin solution.
Similar content being viewed by others
References
Duan F, Wang EQ, Lam MG, et al. Superselective chemoembolization of HCC: comparison of short-term safety and efficacy between drug-eluting LC beads, quadraspheres, and conventional ethiodized oil emulsion. Radiology. 2016;278(2):612–21.
Huppert P, Wenzel T, Wietholtz H, et al. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population. Cardiovasc Interv Radiol. 2014;37(1):154–64.
Narayanan G, Barbery K, Suthar R, et al. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer. Anticancer Res. 2013;33(5):2077–83.
Miyayama S, Matsui O, Taki K, et al. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Interv Radiol. 2006;29(1):39–48.
Guiu B, Deschamps F, Aho S, et al. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. J Hepatol. 2012;56(3):609–17.
Ebert M, Ebert J, Berger G. Intravital microscopic research of microembolization with degradable starch microspheres. J Drug Deliv. 2013;2013:242060.
Nishiofuku H, Tanaka T, Matsuoka M, et al. Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study. J Vasc Interv Radiol. 2013;24(1):56–65.
Akahori T, Sho M, Tanaka T, et al. Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors. Anticancer Res. 2013;33(8):3355–8.
Takada K, Kawamura T, Inai M, et al. Pharmacokinetics of cisplatin in analbuminemic rats. Biopharm Drug Dispos. 1999;20(9):421–8.
Yoshikawa M, Ono N, Yodono H, et al. Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res. 2008;38(5):474–83.
Shen DW, Akiyama S, Schoenlein P, et al. Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes. Br J Cancer. 1995;71(4):676–83.
Ono Y, Yoshimasu T, Ashikaga R, et al. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol. 2000;23(6):564–8.
Maeda N, Osuga K, Shimazu K, et al. In vivo evaluation of cisplatin-loaded superabsorbent polymer microspheres for use in chemoembolization of VX2 liver tumors. J Vasc Interv Radiol. 2012;23(3):397–404.
Pieper CC, Meyer C, Vollmar B, et al. Temporary arterial embolization of liver parenchyma with degradable starch microspheres (EmboCept®S) in a swine model. Cardiovasc Interv Radiol. 2015;38(2):435–41.
Tanaka T, Nishiofuku H, Maeda S, et al. Repeated bland-TAE using small microspheres injected via an implantable port-catheter system for liver metastases: an initial experience. Cardiovasc Interv Radiol. 2014;37(2):493–7.
Erinjeri JP, Salhab HM, Covey AM, et al. Arterial patency after repeated hepatic artery bland particle embolization. J Vasc Interv Radiol. 2010;21(4):522–6.
Rao PP, Pascale F, Seck A, et al. Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor model. Cardiovasc Interv Radiol. 2012;35(6):1448–59.
Ramirez LH, Munck JN, Bognel C, et al. Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases. Br J Cancer. 1993;68(2):277–81.
Sadahiro S, Suzuki T, Ishikawa K. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model. Jpn J Clin Oncol. 2003;33(8):377–81.
Acknowledgements
We thank Ms. Marian Pahud for advice in submitting this article. This work was partially supported by Grant-in-Aid for Scientific Research (C), 26461868, and Nara Medical University Grant-in-Aid for Collaborative Research Projects.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflicts of interest and financial disclosures to declare.
Research Involving Animal and Human Rights
All applicable institutional and/or national guidelines for the care and use of animals were followed.
Rights and permissions
About this article
Cite this article
Sato, T., Tanaka, T., Nishiofuku, H. et al. Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model. Cardiovasc Intervent Radiol 40, 438–444 (2017). https://doi.org/10.1007/s00270-016-1512-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-016-1512-1